US President Donald Trump announced on Friday that his administration will impose a 100% tariff on branded and patented pharmaceuticals starting October 1, 2025, unless companies set up production in ...
A new generic oral anticoagulant in orodispersible film formulation has won regulatory support in Europe, potentially broadening access and ease of use for patients requiring anticoagulation across ...
WASHINGTON (AP) — Federal officials have approved another generic version of the abortion pill mifepristone, a regulatory formality that quickly triggered pushback from anti-abortion groups and ...
Indian pharmaceutical exports, including generic drugs, are unlikely to be affected by US President Donald Trump's recent announcement of 100 per cent tariffs on “any branded or patented" drugs ...
US President Donald Trump’s latest tariff missile imposing a 100% levy on branded or patented pharmaceuticals is unlikely to have much impact on India’s drug industry that mostly ships generic or ...
MORRISTOWN, N.J., Sept. 23, 2025 /PRNewswire/ -- Alvogen Pharma US, Inc. ("Alvogen"), a privately owned US-based pharmaceutical company, today announced a definitive agreement by its shareholders to ...
MMA president Dr R Thirunavukarasu said mandating prescriptions by active ingredient shifts decision-making away from doctors to corporate payers. The Malaysian Medical Association (MMA) has renewed ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
PETALING JAYA: The Malaysian Medical Association (MMA) strongly opposes a recent circular mandating doctors to prescribe long-term medications by active ingredient only, as such a “generic-only” ...
Hyderabad:Boston Consulting Group (BCG) has announced the opening of its Hyderabad office at Salarpuria Sattva Knowledge City in Hitec City, underscoring the city’s growing importance as a business ...
Pharma major Lupin Ltd on Wednesday announced that it has received tentative approval from the US Food and Drug Administration (USFDA) to market its generic version of Bictegravir, Emtricitabine, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results